Shares of Shein Global Holdings have plunged to their lowest level since the company’s recent Hong Kong IPO, pressured by a fresh ‘underperform’ rating from Jefferies and safety recalls of contact lenses in Australia and New Zealand.
- Shein shares dropped 9% to HK$36.40, lowest since IPO
- Jefferies issues 'underperform' rating, targets HK$26
- Contact lens recalls in Australia and New Zealand raise safety flags
What happened
Shein Global Holdings experienced a sharp decline in its share price, dropping as much as 10% during trading on Monday and closing down 9% at HK$36.40. This represents the lowest price point since its listing on the Hong Kong stock exchange on September 1. The stock is now trading 25% below its initial public offering price of HK$48.56. Adding to the negative sentiment, Jefferies initiated coverage with an 'underperform' rating and set a lower target price of HK$26, signaling expectations of further downside potential.
At the same time, Shein is grappling with product safety recalls involving its contact lenses in both Australia and New Zealand. Authorities flagged potential contamination with Burkholderia cepacia complex bacteria, which poses risk of eye infections. This recall compounds challenges for Shein as it navigates operational and reputational pressures shortly after its high-profile IPO.
Why it matters
The stock price decline highlights investor concerns about Shein’s ability to sustain its competitive advantages amid shifting regulatory and market dynamics. Jefferies analysts cited growing costs linked to Shein’s supply chain expansion outside China and the end of low-value parcel advantages under new US and EU tariffs, which increase costs for the company’s historically China-dependent logistics model. These pressures could erode Shein's margins and slow its rapid product turnover.
The product recall raises questions about quality control and safety standards as Shein scales internationally. This incident could impact consumer trust and regulatory scrutiny in key markets, complicating the company’s global growth ambitions. With a current market capitalization significantly lower than its 2022 peak, Shein faces challenges to prove it can maintain profitability and operational resilience.
What to watch next
Investors will closely monitor Shein’s ability to manage supply chain costs while maintaining its fast-fashion appeal. Key indicators will include the company’s success with diversifying suppliers beyond Guangdong, China, and how effectively it employs technology like artificial intelligence to reduce costs. Jefferies’ report suggests a wide range of possible outcomes, with share prices potentially dropping further to HK$16 or rising to HK$45 under an optimistic scenario involving cost efficiencies and ecosystem localization.
Additionally, regulatory responses and further product safety developments in markets such as Australia, New Zealand, and beyond will be critical. How Shein addresses the contact lens recall and implements quality assurance measures will influence its brand reputation and regulatory compliance. The company’s forthcoming earnings reports and strategic updates will provide insight into how it navigates these headwinds in the near term.